| Sep 18 |
Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
|
| Sep 4 |
Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
|
| Jul 30 |
Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
|
| Jul 25 |
Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
|
| Jul 10 |
Mainz Biomed submits FDA breakthrough device designation for its CRC screening test
|
| Jul 10 |
Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test
|
| Jul 9 |
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
|
| Jul 9 |
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
|
| Jul 2 |
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
|
| Jul 2 |
Mainz Biomed Provides Half Year 2024 Corporate Update
|
